| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.25 | 0.08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |